CAM
AMGN icon

CMT Asset Management’s Amgen AMGN Stock Holding History

CMT Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,400
Closed -$2.17M – 200
2015
Q4 		$2.17M Buy
13,400
+2,800
+26% +$440K 0.11% 129
2015
Q3 		$1.47M Buy
10,600
+200
+2% +$31.5K 0.08% 140
2015
Q2 		$1.6M Buy
10,400
+1,000
+11% +$160K 0.1% 140
2015
Q1 		$1.5M Buy
+9,400
New +$1.48M 0.11% 128

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CMT Asset Management's AMGN Position: Q4 2015 in Review

CMT Asset Management sold out of Amgen (AMGN) in Q4 2015, closing a stake of 4,323 shares — an estimated $680K sold.

CMT Asset Management first reported a position in AMGN in Q2 2015 and held it in 2 quarters. The position peaked at $1.45M in Q2 2015. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • CMT Asset Management reported no remaining Amgen position as of Q4 2015 after selling out during the quarter.
  • CMT Asset Management sold 4,323 Amgen shares in Q4 2015, an estimated $680K.
  • CMT Asset Management first reported a position in Amgen in Q2 2015 and held it in 2 quarters.
  • CMT Asset Management's Amgen position peaked at $1.45M in Q2 2015.
  • 1,453 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on CMT Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.